Company intelligence / Profile preview

JADBio

Heraklion, Greece

Ownership: Private
Development stage: Other

Overview

JADBio is a no-code AutoML platform that enables life scientists to build predictive models and discover biomarkers without coding expertise. The platform automates feature selection, model optimization, and knowledge discovery across multi-omics datasets. Over 40 discoveries have been published using JADBio across biomedical, diagnostic, and pharmaceutical applications.

Industry: Drug Discovery Services

Partnerships

IndivumedBioLizardBlack Arrow BiotechDiamiR Biosciences

Beyond the preview

Go deeper on JADBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JADBio.

Explore the full profile